Search
News
Press releases
Contact
Work with us
About us
Idea and vision
Management Team
Board of Directors
Scientific Advisory Board
R&D
Tech platform: Abiprot® antibody platform
Scientific publications
Portfolio
Pipeline
Programs
Corporate Governance
Rights issue 2023
ANNUAL GENERAL MEETING 2022
Extra General Meeting 2022
Previous Annual General Meetings
Board of Directors and Management
Nomination Committee
Articles of Association
Investor Relations
Financial Reports
Annual Reports for the years 2016–2021
Convertible bonds rights issue 2022
Investor Relations contact
Partnering
Partnership & Collaboration
Partnering Contact
Oblique
News
Connect with us on LinkedIn
Connect with us on LinKedin
https://www.linkedin.com/company/oblique-therapeutics-ab
